Adial Pharmaceuticals, Inc. (ADIL)
ADIL Stock Price Chart
Explore Adial Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ADIL price movements and trends.
ADIL Company Profile
Discover essential business fundamentals and corporate details for Adial Pharmaceuticals, Inc. (ADIL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Jul 2018
Employees
5.00
Website
https://www.adialpharma.comCEO
Cary John Claiborne MBA
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
ADIL Financial Timeline
Browse a chronological timeline of Adial Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.09.
Earnings released on 13 Aug 2025
EPS came in at -$0.18 surpassing the estimated -$0.22 by +18.18%.
Earnings released on 14 May 2025
EPS came in at -$0.34 surpassing the estimated -$0.50 by +32.00%.
Earnings released on 4 Mar 2025
EPS came in at -$0.15 surpassing the estimated -$0.38 by +60.53%.
Earnings released on 13 Nov 2024
EPS came in at -$0.38 surpassing the estimated -$0.50 by +24.00%.
Earnings released on 13 Aug 2024
EPS came in at -$0.59 falling short of the estimated -$0.39 by -51.28%.
Earnings released on 14 May 2024
EPS came in at -$0.68 falling short of the estimated -$0.51 by -33.33%.
Earnings released on 1 Apr 2024
EPS came in at -$1.35 falling short of the estimated -$0.76 by -77.63%, while revenue for the quarter reached $32.25K .
Earnings released on 14 Nov 2023
EPS came in at -$1.14 matching the estimated -$1.14.
Earnings released on 21 Aug 2023
EPS came in at -$1.33 surpassing the estimated -$1.50 by +11.33%.
Stock split effective on 7 Aug 2023
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 May 2023
EPS came in at -$2.75 surpassing the estimated -$3.50 by +21.43%.
Earnings released on 30 Mar 2023
EPS came in at -$2.75 surpassing the estimated -$3.75 by +26.67%.
Earnings released on 14 Nov 2022
EPS came in at -$3.00 surpassing the estimated -$4.50 by +33.33%.
Earnings released on 16 Aug 2022
EPS came in at -$4.00 matching the estimated -$4.00.
Earnings released on 16 May 2022
EPS came in at -$3.25 surpassing the estimated -$4.25 by +23.53%.
Earnings released on 28 Mar 2022
EPS came in at -$7.00 falling short of the estimated -$0.21 by -3.23K%.
Earnings released on 15 Nov 2021
EPS came in at -$5.50 matching the estimated -$5.50.
Earnings released on 12 Aug 2021
EPS came in at -$6.25 falling short of the estimated -$0.20 by -3.02K%.
Earnings released on 17 May 2021
EPS came in at -$7.50 .
Earnings released on 22 Mar 2021
EPS came in at -$6.00 falling short of the estimated -$0.25 by -2.30K%.
Earnings released on 13 Nov 2020
EPS came in at -$6.00 falling short of the estimated -$0.18 by -3.23K%.
ADIL Stock Performance
Access detailed ADIL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.